AbCellera Biologics ABCL
$ 2.89
5.68%
Quarterly report 2024-Q3
added 11-04-2024
Country |
Canada |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Carl L. Hansen |
Employees in the company |
174 |
Shares |
289 M |
Market Cap[1] |
$ 836 M |
EBITDA (LTM) |
$ -282 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.